Rank;Global Rank;Institution;Country;Sector
1;135;Novo Nordisk A/S;DNK;Companies
2;142;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
3;206;AstraZeneca, United Kingdom;GBR;Companies
4;220;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
5;223;Bayer AG, Germany;DEU;Companies
6;242;Hoffmann-La Roche Ltd, Switzerland;CHE;Companies
7;267;Janssen Research & Development, LLC;BEL;Companies
8;282;GlaxoSmithKline, United Kingdom;GBR;Companies
9;302;Philips Research, Eindhoven;NLD;Companies
10;307;VTT Technical Research Centre of Finland;FIN;Companies
11;328;Nestle Switzerland;CHE;Companies
12;338;Merck KGaA, Germany;DEU;Companies
13;351;Bruker Corp;DEU;Companies
14;395;Novartis, Switzerland;CHE;Companies
15;397;IMEC International;BEL;Companies
16;453;Pfizer Inc, United Kingdom;GBR;Companies
17;454;Siemens AG, Germany;DEU;Companies
18;470;Boehringer Ingelheim GmbH Germany;DEU;Companies
19;512;Danone Nederland BV;NLD;Companies
19;512;GlaxoSmithKline, Belgium;BEL;Companies
21;531;AstraZeneca, Sweden;SWE;Companies
22;571;BASF, Germany;DEU;Companies
23;617;SINTEF Group;NOR;Companies
24;751;Syngenta, United Kingdom;GBR;Companies
25;772;Eli Lilly and Company Ltd., United Kingdom;GBR;Companies
26;909;Sincrotrone Trieste;ITA;Companies